
%201.webp)



%201.webp)





LSPedia 的全球序列化系列
序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
欢迎来到 LspEdia,在这里,创新与奉献精神相结合。
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。


%201.webp)



%201.webp)





序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。

在厄瓜多尔,国家监管、控制和健康监督局(ARCSA)制定了全面的药品可追溯性要求,以确保整个供应链中药品的真实性和安全性。这些法规管理药品、生物制品和医疗器械的可追溯性,以保护公共健康,并严格控制厄瓜多尔的药品分销。

ARCSA要求对药品和医疗器械实施唯一可追溯性代码(CUT)。具体而言,对于医疗器械,该规范符合国际医疗器械监管机构论坛建立的通用设备识别(UDI)系统。CUT/UDI 必须包含基本的识别信息,例如全球贸易项目代码 (GTIN)、批次/批号、到期日期,对于植入式设备,还必须包含强制性序列号。
厄瓜多尔的药品法规要求在整个供应链过程中采集详细的数据。所有物流运输都必须仔细记录,包括隔离、释放、分发、接待和交付给患者。该系统还跟踪产品取消、损失、盗窃、转让、到期、退货、提款和临床试验产品。这种强大的报告框架可以对药品从生产到患者的全过程进行全面监督。
ARCSA法规对药品施加了特定的标签要求。CUT 必须使用二维条形码在包装(主要和/或次要)上打印,并且必须放在可见的位置。在包装尺寸允许的情况下,还必须显示人类可读的信息,包括全球贸易项目代码、到期日期、批号和序列号。如果无法在包装上打印,则允许使用防盗贴纸或带有 CUT 的粘合剂。
ARCSA管理着一个集中的可追溯性数据库,该数据库是厄瓜多尔药品监督系统的支柱。这个复杂的数据库存储了与产品物流有关的所有记录,并实施了严格的访问控制,只允许获得授权的人员与系统进行交互。它旨在为重复代码或未经授权的操作等异常行为提供警报,同时确保数据安全和隐私,尤其是患者信息的安全和隐私。
Our team of compliance experts possesses in-depth knowledge of iTS and Turkish pharmaceutical regulations. From serialization strategies to data reporting, we guide your organization through the intricacies of compliance, ensuring a smooth and informed journey.
Leverage our state-of-the-art compliance solution, designed to integrate seamlessly with iTS requirements. Our technology ensures accuracy, efficiency, and real-time visibility, empowering your organization to meet and exceed compliance expectations.
Compliance is not just about meeting today's standards; it's about preparing for the future. Our solution is designed to evolve with regulatory changes, ensuring that your organization remains at the forefront of compliance in the dynamic Turkish pharmaceutical landscape.
We believe in transparent collaboration. Partner with us, and we'll work closely with your team to implement and maintain compliance measures. Our goal is to build a resilient, compliant, and future-ready pharmaceutical supply chain together.






We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.
Stay connected with us on social media and subscribe to our newsletter to receive the latest updates, insights, and innovations from LSPedia.
Ecuador regulates pharmaceutical products through the National Agency for Regulation, Control and Health Surveillance (ARCSA). The country has established requirements to strengthen medicine identification and improve traceability across the pharmaceutical supply chain.
The regulatory framework focuses on standardized product identification using GS1 barcodes and the capture of product data to support traceability and product verification. The objective is to reduce counterfeit medicines and improve regulatory visibility of pharmaceutical distribution.
Manufacturers, importers, and distributors supplying medicines to Ecuador must ensure pharmaceutical products include standardized barcode identification and maintain traceability records throughout the distribution chain.
Pharmaceutical products marketed in Ecuador must include barcode identification that supports product traceability.
The barcode used on secondary packaging typically follows GS1 standards and contains key product identification information.
Common data elements included in the barcode are:
The barcode enables identification of the product during distribution and dispensing operations.
Human readable product information printed on packaging must match the encoded barcode data.
Serialization of individual medicine packs using unique serial numbers is not currently mandated nationwide.
2012 – ARCSA established to regulate medicines, medical devices, and other health products in Ecuador.
2014 onward – Strengthening of pharmaceutical supply chain oversight and traceability requirements through labeling and identification standards.
Ongoing – Continued monitoring and regulatory initiatives to improve medicine supply chain security.
Traceability requirements focus on batch level product identification rather than individual pack serialization.
| Operation | Data to Report | When to Report |
Commission | GTIN, Serial, Batch, Expiry Parent SSCC, Child Serials Sender GLN, Receiver GLN, SSCC or Serial List | During packaging before shipment When creating cases or pallets Before dispatch |
ReceivingImport Clearance Supply to Pharmacy | GTIN, Serial, Batch, Expiry Parent SSCC, Child Serials Sender GLN, Receiver GLN, SSCC or Serial List | During packaging before shipment When creating cases or pallets Before dispatch |
Returns Decommission | Serial status and reference Reason and serials | When return is approved When product is destroyed or removed |
Ecuador does not currently operate a nationwide pharmaceutical serialization repository that requires serial level reporting of supply chain events.
Traceability is supported through:
Companies must maintain traceability documentation that allows regulators to identify product batches and distribution pathways when required.
There is no regulatory requirement for aggregation or serialized packaging hierarchies in Ecuador.
Manufacturers and distributors may implement logistics identifiers such as SSCC internally to support warehouse operations and shipment tracking.
Aggregation practices are typically used for operational efficiency rather than regulatory compliance.
We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.